The National Institute of Clinical Excellence (NICE) are currently welcoming applications from people who would like to join the groups that develop Quality Standards.
Thrombolysis, where drugs are injected into the blood to break up a blood clot, is one of the main treatments used to treat people who are having a stroke caused by a clot. Currently a drug called alteplase is used in thrombolysis. But the researchers think that another drug, called tenecteplase, may be more effective than alteplase. This study will investigate if this is the case.
We pride ourselves on providing high quality information and delivering an excellent service to those affected by stroke. Here you can read about our commitment to quality and our standards.
Find out the results of our impact and satisfaction survey and how we're performing against Information Governance policies and standards. You can also read about our achievements in research and how we monitor the performance of our helpline against our service standards.
Comparing two treatment strategies in patients with visual problems after stroke
Does improved oral health care in stroke care settings reduce the occurrence of pneumonia after stroke – a pilot trial.
After a stroke, you need accurate and trustworthy information to help you understand what has happened, and to support you in making informed choices for your future.
This research aims to improve outcomes for Intracerebral Haemorrhage (ICH) patients by developing new emergency treatments to reduce swelling in the brain after ICH, and improving the care they receive.
Find out about our Stroke Helpline and Information Service, the service standards we work to, and how we perform against these.